Prediction Case File
YouTubeEvaluation Complete

Learn How Wall Street is Using AI to Profit https://felixfriends.org/training

1 extracted signal · 1 resolved · 0 still active

Felix & Friends (Goat Academy) profile imageFelix & Friends (Goat Academy)03 Oct 2025, 17:00 UTC
Video preview for Learn How Wall Street is Using AI to Profit  https://felixfriends.org/training
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
0
Canonical correct result
Failed
1
Canonical failed result
Resolved success
0%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis identifies US stocks set to benefit from a trade war, creating opportunities in US companies. Identifies pharma, defense, semiconductors as likely winners. 50% tariff is being imposed on India. Identifies winners as CVS (a generic drug distributor), Walgreens, McKesson. For defense, Lockheed Martin and Boeing are expected to benefit. For Clean energy, General Electric. Applied Materials is identified to profit.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

Felix & Friends (Goat Academy)

Tracked signals
338
Historical success
59.2%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.